Trade this ETF at your broker
Index | Solactive Genomics |
Investment focus | Equity, World, Health Care |
Fund size | EUR 7 m |
Total expense ratio | 0.50% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 28.29% |
Inception/ Listing Date | 2 November 2021 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Global X |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | SEI Investments – Global Fund Services Limited |
Investment Advisor | |
Custodian Bank | Brown Brothers Harriman & Co. |
Revision Company | PwC |
Fiscal Year End | - |
Swiss representative | 1741 Fund Solutions AG |
Swiss paying agent | Tellco AG |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty |
Moderna, Inc. | 5.44% |
Bio-Techne | 4.83% |
Natera | 4.62% |
Agilent Technologies | 4.16% |
BioNTech SE | 4.12% |
Intellia Therapeutics | 4.08% |
Alnylam Pharmaceuticals | 4.03% |
NL0015001WM6 | 4.00% |
Arrowhead Pharmaceuticals | 3.97% |
Myriad Genetics | 3.82% |
United States | 84.23% |
Germany | 4.12% |
Switzerland | 3.81% |
China | 2.73% |
Other | 5.11% |
Health Care | 95.86% |
Other | 4.14% |
Broker | Rating | Execution fee | Account fee | More information |
---|---|---|---|---|
free of charge | free of charge | View offer* | ||
free of charge | free of charge | View offer* | ||
free of charge | free of charge | View offer* | ||
free of charge | free of charge | View offer* | ||
free of charge | free of charge | View offer* |
YTD | -1.36% |
1 month | +2.82% |
3 months | +4.30% |
6 months | -0.27% |
1 year | -8.54% |
3 years | - |
5 years | - |
Since inception (MAX) | -46.43% |
2023 | -11.72% |
2022 | -32.85% |
2021 | - |
2020 | - |
Volatility 1 year | 28.29% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | -0.30 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -26.26% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -57.09% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
Borsa Italiana | EUR | GNOM | - - | - - | - |
gettex | EUR | GN0M | - - | - - | - |
Borsa Italiana | EUR | - | GNOMEUIV | GNOM.MI | GHCO/Virtu |
London Stock Exchange | USD | GNOM | GNOM LN GNOMUSIV | GNOM.L GNOMiv.P | GHCO/Virtu |
London Stock Exchange | GBP | GNOG | GNOG LN GNOMGBIV | GNOG.L | GHCO/Virtu |
SIX Swiss Exchange | CHF | GNOM | GNOMCHIV | GNOM.S | GHCO/Virtu |
XETRA | EUR | GN0M | GNOMEUIV | GN0M.DE | GHCO/Virtu |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
WisdomTree BioRevolution UCITS ETF USD Acc | 3 | 0.45% p.a. | Accumulating | Full replication |